August Private Market Update
Updated 8/24/2026, 7:47:34 AMForge reviews all bids and asks to ensure fair pricing and requires a 30-day expiration to maintain accuracy. Register to view all opportunities, last matched price and additional transactional details.
| Funding Date | Round | Amount Raised | Price Per Share | Post-Money Valuation 3 | Key Investors | |
|---|---|---|---|---|---|---|
| 10/14/2025 | Series E | $900M | $53.57 | $11B | Atreides, Fidelity, Iconiq, Lateralus Holdings, Matter Venture Partners, Whale Rock Capital | |
|
Price Per Share
$53.57
Shares Outstanding
16,800,448
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Atreides, Fidelity, Iconiq, Lateralus Holdings, Matter Venture Partners, Whale Rock Capital
|
||||||
| 12/19/2024 | Series D | $200M | $25.69 | $5.2B | 2468 Ventures, Anticipation Ventures, CTR Capital, DexCom, Fidelity, Okeanos, Sequence | |
|
Price Per Share
$25.69
Shares Outstanding
7,785,129
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
2468 Ventures, Anticipation Ventures, CTR Capital, DexCom, Fidelity, Okeanos, Sequence
|
||||||
| 04/05/2022 | Series C-3 | $282.66M | $14.87 | $2.55B | 345 Partners, Beyond The Game Network, CTR Capital, Forerunner, J2 Ventures, Lifeline Ventures, Microtech Ventures, Msd Capital, Nathaniel Turner, One Capital, Sequence, Stadia Ventures, Sternhill Associates | |
|
Price Per Share
$14.87
Shares Outstanding
19,008,876
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
345 Partners, Beyond The Game Network, CTR Capital, Forerunner, J2 Ventures, Lifeline Ventures, Microtech Ventures, Msd Capital, Nathaniel Turner, One Capital, Sequence, Stadia Ventures, Sternhill Associates
|
||||||
| 04/05/2022 | Series C-2 | $139.55M | $14.26 | $2.55B | 345 Partners, Beyond The Game Network, CTR Capital, Forerunner, J2 Ventures, Lifeline Ventures, Microtech Ventures, Msd Capital, Nathaniel Turner, One Capital, Sequence, Stadia Ventures, Sternhill Associates | |
|
Price Per Share
$14.26
Shares Outstanding
9,786,057
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
345 Partners, Beyond The Game Network, CTR Capital, Forerunner, J2 Ventures, Lifeline Ventures, Microtech Ventures, Msd Capital, Nathaniel Turner, One Capital, Sequence, Stadia Ventures, Sternhill Associates
|
||||||
| 05/04/2021 | Series C-1 | $100M | $4.33 | $899.61M | Bedford Ridge, Eisai, Elysian Park Ventures, Forerunner, Jazz Venture Partners, Lifeline Ventures, Marc Benioff, Metaplanet Holdings, Msd Capital, Next Ventures, One Capital, Square, Tcg, Temasek | |
|
Price Per Share
$4.33
Shares Outstanding
23,084,559
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bedford Ridge, Eisai, Elysian Park Ventures, Forerunner, Jazz Venture Partners, Lifeline Ventures, Marc Benioff, Metaplanet Holdings, Msd Capital, Next Ventures, One Capital, Square, Tcg, Temasek
|
||||||
| 03/17/2020 | Series B-1 | $2.07M | $0.79 | $139.68M | Able Partners, Alumni Ventures, Forerunner, Gradient, J2 Ventures, Jazz Venture Partners, Lateralus Holdings, Next Ventures, Reverb Capital, Sanno Capital, Square | |
|
Price Per Share
$0.79
Shares Outstanding
2,608,739
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Able Partners, Alumni Ventures, Forerunner, Gradient, J2 Ventures, Jazz Venture Partners, Lateralus Holdings, Next Ventures, Reverb Capital, Sanno Capital, Square
|
||||||
| 03/17/2020 | Series B-2 | $16.22M | $0.75 | $139.68M | Able Partners, Alumni Ventures, Forerunner, Gradient, J2 Ventures, Jazz Venture Partners, Lateralus Holdings, Next Ventures, Reverb Capital, Sanno Capital, Square | |
|
Price Per Share
$0.75
Shares Outstanding
21,571,278
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Able Partners, Alumni Ventures, Forerunner, Gradient, J2 Ventures, Jazz Venture Partners, Lateralus Holdings, Next Ventures, Reverb Capital, Sanno Capital, Square
|
||||||
| 12/03/2018 | Series A-2 | $3.59M | $0.38 | $59.21M | Apolo Anton Ohno, B37 Ventures, Blue Ivy Ventures, Bold Capital Partners, Dave Morin, David Chang, Drew Brees, Earl Thomas III, G9 Ventures, Jaan Tallinn, Jimmy Johnson, Joi Ito, Keisuke Honda, Kevin Lin, Lance Armstrong, Lateralus Holdings, Lifeline Ventures, Manu Ginobili, Msd Capital, Neil Strauss, Nick Foles, Proxy, Ryan Rzepecki, Sam Harris, Shaquille O'Neal, Sternhill Associates, Steve Chen, Tesi, Will Smith | |
|
Price Per Share
$0.38
Shares Outstanding
9,345,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Apolo Anton Ohno, B37 Ventures, Blue Ivy Ventures, Bold Capital Partners, Dave Morin, David Chang, Drew Brees, Earl Thomas III, G9 Ventures, Jaan Tallinn, Jimmy Johnson, Joi Ito, Keisuke Honda, Kevin Lin, Lance Armstrong, Lateralus Holdings, Lifeline Ventures, Manu Ginobili, Msd Capital, Neil Strauss, Nick Foles, Proxy, Ryan Rzepecki, Sam Harris, Shaquille O'Neal, Sternhill Associates, Steve Chen, Tesi, Will Smith
|
||||||
| 12/03/2018 | Series A-1 | $6.96M | $0.30 | $59.21M | Apolo Anton Ohno, B37 Ventures, Blue Ivy Ventures, Bold Capital Partners, Dave Morin, David Chang, Drew Brees, Earl Thomas III, G9 Ventures, Jaan Tallinn, Jimmy Johnson, Joi Ito, Keisuke Honda, Kevin Lin, Lance Armstrong, Lateralus Holdings, Lifeline Ventures, Manu Ginobili, Msd Capital, Neil Strauss, Nick Foles, Proxy, Ryan Rzepecki, Sam Harris, Shaquille O'Neal, Sternhill Associates, Steve Chen, Tesi, Will Smith | |
|
Price Per Share
$0.30
Shares Outstanding
23,485,035
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Apolo Anton Ohno, B37 Ventures, Blue Ivy Ventures, Bold Capital Partners, Dave Morin, David Chang, Drew Brees, Earl Thomas III, G9 Ventures, Jaan Tallinn, Jimmy Johnson, Joi Ito, Keisuke Honda, Kevin Lin, Lance Armstrong, Lateralus Holdings, Lifeline Ventures, Manu Ginobili, Msd Capital, Neil Strauss, Nick Foles, Proxy, Ryan Rzepecki, Sam Harris, Shaquille O'Neal, Sternhill Associates, Steve Chen, Tesi, Will Smith
|
||||||
| 11/12/2015 | Series Seed-3 | $774,694.80 | $0.17 | $11.19M | Lifeline Ventures, Proxy | |
|
Price Per Share
$0.17
Shares Outstanding
4,622,284
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lifeline Ventures, Proxy
|
||||||
| 11/12/2015 | Series Seed-2 | $147,855.29 | $0.15 | $11.19M | Lifeline Ventures, Proxy | |
|
Price Per Share
$0.15
Shares Outstanding
1,006,503
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lifeline Ventures, Proxy
|
||||||
| 11/12/2015 | Series Seed-1 | $390,277.03 | $0.05 | $11.19M | Lifeline Ventures, Proxy | |
|
Price Per Share
$0.05
Shares Outstanding
7,728,258
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Lifeline Ventures, Proxy
|
||||||
| Trade Metrics | Last Funding Round | |||||||
|---|---|---|---|---|---|---|---|---|
| Company | Forge Price | Last Matched | Round | Post-Money Valuation 3 | Price Per Share | Amount Raised | ||
 | Brightline | Not available | $xx.xx | Series C | $705.25M | $8.73 | $115.2M | |
 | Calm | Not available | $xx.xx | Series 1 | $404.67M | $2.38 | $25.07M | |
 | Flo Health | Not available | $xx.xx | Series C | $1.2B | $59.62 | $200M | |
 | Function Health | Not available | $xx.xx | Series B-2 | $2.94B | $92.23 | $94.11M | |
 | Headway | Not available | $xx.xx | Series D-2 | $2.38B | $12.01 | $30.02M | |
 | Included Health | Not available | $xx.xx | Series E | $1.13B | $3.22 | $103.04M | |
 | Midi Health | Not available | $xx.xx | Series D | $1B | $10.06 | $100M | |
 | Ro | Not available | $xx.xx | Series D-1 | $7.19B | $15.33 | $100M | |
 | Spring Health | Not available | $xx.xx | Series D Aegis | $3.52B | $69.22 | $130M | |
 | ZocDoc | $5.00 -$1.33 (21.01%) | $xx.xx | Series D-2 | $2.62B | $29.29 | $100M | |
Updated on: Aug 20, 2026
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.
The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.
Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.
